Soft launch of first indigenous antibiotic to combat AMR, Nafithromycin, announced by Dr Jitendra…
The development of Nafithromycin represents 14 years of research and an investment of ₹500 crores, with clinical trials spanning…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
community-acquired bacterial pneumonia
FDA approves Nabriva’s antibiotic for pneumonia
The drug is also Nabriva's first to be approved by the FDA and is expected to be launched in mid-September